(Total Views: 413)
Posted On: 03/31/2020 5:06:27 PM
Post# of 149074
Re: thriftycents #24370
The one question I’d like him to discuss and one which I’m sure he’s working on: manufacturing for demand.
Obviously not every COVID19 patient will need leronlimab, but any displaying shortness of breath and/or requiring hospitalization should receive the medication to prevent further complications. That is still a significant number of patients in the U.S. and around the world.
Obviously not every COVID19 patient will need leronlimab, but any displaying shortness of breath and/or requiring hospitalization should receive the medication to prevent further complications. That is still a significant number of patients in the U.S. and around the world.
(1)
(0)Scroll down for more posts ▼
